1.00
0.99%
0.0098
Kronos Bio Inc 주식(KRON)의 최신 뉴스
Short Interest in Kronos Bio, Inc. (NASDAQ:KRON) Increases By 16.5% - MarketBeat
Layoff Tracker: Notch Therapeutics to ‘Significantly Reduce’ Workforce - BioSpace
We Think Kronos Bio (NASDAQ:KRON) Needs To Drive Business Growth Carefully - Yahoo Finance
Analyzing Kronos Bio (NASDAQ:KRON) and Aerovate Therapeutics (NASDAQ:AVTE) - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8% – Here’s What Happened - Defense World
Kronos Bio (NASDAQ:KRON) Stock Price Down 1.8%Should You Sell? - MarketBeat
Kronos Bio ends partnership with Genentech By Investing.com - Investing.com Australia
Kronos Bio ends partnership with Genentech - Investing.com India
Kronos Bio Ends Collaboration with Genentech and Roche - TipRanks
Kronos Bio (NASDAQ:KRON) Trading 8.5% HigherHere's Why - MarketBeat
Struggling Bay Area biotech firm Kronos, once worth $1B, lays off almost entire staff - SFGATE
Kronos Bio, Inc. (KRON) Reports Q3 Loss, Tops Revenue Estimates - MSN
KRON (Kronos Bio) Profitability Rank : 1 (As of Sep. 2024) - GuruFocus.com
A Look At The Behavior Of Kronos Bio Inc (KRON) Stock - Stocks Register
Kronos Bio announces interim CEO; over 80% of staff reduction - MSN
Kronos Bio announces interim CEO and workforce cuts of 83% - Yahoo Finance
Kronos Bio Stock Jumps After Deep Workforce Cuts And CEO Shuffle: Retail Aligns With Shake-Up - MSN
Strategic shift at Kronos creates CEO vacancy - The Pharma Letter
Kronos Bio to lay off 83% of staff as CEO steps down - The Business Journals
Kronos Bio announces layoffs and executive changes By Investing.com - Investing.com Nigeria
Kronos Bio, Inc. Announces Management Changes, Effective December 3, 2024 - Marketscreener.com
Kronos Bio, Inc. Announces CEO Changes, Effective December 3, 2024 - Marketscreener.com
Kronos Bio Shakes Up LeadershipCuts 83% Of Workforce Amid Strategic Overhaul - AOL
Biotech with Cambridge lab slashes 83% of staff, CEO departs - NBC Boston
Kronos Bio announces layoffs and executive changes - Investing.com India
Kronos Bio Announces CEO Transition and Reduction in Force - The Manila Times
Kronos Bio stock in focus on CEO change, layoffs (KRON:NASDAQ) - Seeking Alpha
Kronos Bio to Cut 83% Of Workforce, Names Interim CEO - MarketWatch
Kronos Bio Cuts 83% of Workforce, Names New CEO Amid Strategic Review | KRON Stock News - StockTitan
Kronos Bio Restructures Workforce and Leadership - TipRanks
Kronos Bio : Management Change/Compensation Form 8 K - Marketscreener.com
Kronos, Idorsia plan layoffs; PTC shelves ALS drug - Yahoo Finance
KRON (Kronos Bio) Cash Flow from Discontinued Operations : $0.00 Mil (TTM As of Sep. 2024) - GuruFocus.com
자본화:
|
볼륨(24시간):